stockrowHCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.59%
- EPS
- +23.8%
- Free cash flow
- −0.77%
- Total debt
- +13.4%
Quarter to September 2026, against a year earlier
Follow HCA
Alert me
HCA Healthcare, Inc. (HCA) EBITDA
HCA Healthcare, Inc.'s EBITDA for fiscal 2025 was $15.6B, up 12.2% from $13.9B in fiscal 2024. Over the twelve months to 30 September 2026 it was $15.9B. Over the past ten years it has ranged from $8.0B (fiscal 2015) to $15.6B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 3 consecutive fiscal years. HCA Healthcare, Inc. ranks 1st of 48 Medical Care Facilities companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $15.6B | 12.16% |
| FY2024 | $13.9B | 9.06% |
| FY2023 | $12.8B | 5.50% |
| FY2022 | $12.1B | (4.54%) |
| FY2021 | $12.7B | 25.87% |
| FY2020 | $10.1B | 1.82% |
| FY2019 | $9.9B | 10.10% |
| FY2018 | $9.0B | 8.66% |
| FY2017 | $8.3B | 0.15% |
| FY2016 | $8.3B | 3.80% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $3.9B | (2.72%) |
| Jun 2026 | $4.0B | 5.93% |
| Mar 2026 | $3.8B | (7.59%) |
| Dec 2025 | $4.1B | 6.42% |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| HCA HCA Healthcare, Inc. | $15.9B |
| THC Tenet Healthcare Corporation compare | $7.1B |
| FMS Fresenius Medical Care AG & Co. KGaA compare | $3.8B |
| DVA DaVita Inc. compare | $2.8B |
| UHS Universal Health Services, Inc. compare | $2.7B |
| EHC Encompass Health Corporation compare | $1.5B |
| ENSG The Ensign Group, Inc. compare | $630.9M |
| PACS PACS Group, Inc. compare | $500.6M |
| CHE Chemed Corporation compare | $438.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on HCA
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement